Source: Contract Pharma

Abzena: Abzena Fine-Tunes Its AbZelectPRO Platform for Cell Line Development

Significantly reduced timelines by >30% and improved its overall protein production levels.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Matthew Stober's photo - CEO of Abzena

CEO

Matthew Stober

CEO Approval Rating

82/100

Read more